UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Memory NK cells to forget relapsed AML

Blood, 2022-03, Vol.139 (11), p.1607-1608

Parihar, Robin

2022

Volltextzugriff (PDF)

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment

Cancers, 2020-12, Vol.12 (12), p.3871

2020

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Advances in experimental medicine and biology, 2020, Vol.1224, p.117-140

2020

Volltextzugriff (PDF)

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003237

2021

Volltextzugriff (PDF)

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

Oncoimmunology, 2018-10, Vol.7 (10), p.e1490853-e1490853

2018

Volltextzugriff (PDF)

Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?

Molecular therapy, 2017-05, Vol.25 (5), p.1064-1066

Parihar, Robin

2017

Volltextzugriff (PDF)

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Communications biology, 2021-03, Vol.4 (1), p.368-13, Article 368

2021

Volltextzugriff (PDF)

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

The Journal of clinical investigation, 2002-10, Vol.110 (7), p.983-992

2002

Volltextzugriff (PDF)

CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells

The Journal of immunology (1950), 2005-08, Vol.175 (3), p.1619-1627

2005

Volltextzugriff (PDF)

Interleukin‐2 enhances the natural killer cell response to Herceptin‐coated Her2 / neu‐positive breast cancer cells

European journal of immunology, 2001-10, Vol.31 (10), p.3016-3025

2001

Volltextzugriff (PDF)

Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells

Frontiers in medicine, 2018-12, Vol.5, p.343-343

2018

Volltextzugriff (PDF)

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

Cancer immunology research, 2019-03, Vol.7 (3), p.363-375

2019

Volltextzugriff (PDF)

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

The Journal of immunology (1950), 2003-04, Vol.170 (8), p.4242-4253

2003

Volltextzugriff (PDF)

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Cancer discovery, 2017-11, Vol.7 (11), p.1238-1247

2017

Volltextzugriff (PDF)

Abstract 4734: Suppressive myeloid cells of the solid tumor microenvironment enhance regulatory T cell function and differentially affect CAR-T cell function

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4734-4734

2018

Volltextzugriff (PDF)

NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition

Current hematologic malignancy reports, 2023-12, Vol.18 (6), p.264-272

2023

Volltextzugriff (PDF)

413 Genetic deletion of TIGIT enhances CAR-NK cell function in the solid tumor microenvironment

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A435-A435

2022

Volltextzugriff (PDF)

Overcoming the breast tumor microenvironment by targeting MDSCs through CAR-T cell therapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1032-1032

2021

Volltextzugriff (PDF)

Phase I Study of the Sequential Combination of Interleukin-12 and Interferon Alfa-2b in Advanced Cancer: Evidence for Modulation of Interferon Signaling Pathways by Interleukin-12

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8835-8844

2005

Volltextzugriff (PDF)

816 Blockade of SIRPα on macrophages to enhance CAR T activity against glioblastoma

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A852-A852

2022

Volltextzugriff (PDF)

Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive immunotherapy of B-cell malignancies

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.198-198.6

2017

Volltextzugriff (PDF)

Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics

Science advances, 2020-07, Vol.6 (28), p.eaba6156-eaba6156

2020

Volltextzugriff (PDF)

Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype

Blood, 2017-12, Vol.130, p.2443-2443

2017

Volltextzugriff (PDF)

Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1441, p.195

2016

Volltextzugriff (PDF)

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

The Journal of immunology (1950), 2011-03, Vol.186 (6), p.3401-3409

2011

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(68)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Memory NK cells to forget relapsed AML

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment

Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells

Interleukin‐2 enhances the natural killer cell response to Herceptin‐coated Her2 / neu‐positive breast cancer cells

Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Abstract 4734: Suppressive myeloid cells of the solid tumor microenvironment enhance regulatory T cell function and differentially affect CAR-T cell function

NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition

413 Genetic deletion of TIGIT enhances CAR-NK cell function in the solid tumor microenvironment

Overcoming the breast tumor microenvironment by targeting MDSCs through CAR-T cell therapy

Phase I Study of the Sequential Combination of Interleukin-12 and Interferon Alfa-2b in Advanced Cancer: Evidence for Modulation of Interferon Signaling Pathways by Interleukin-12

816 Blockade of SIRPα on macrophages to enhance CAR T activity against glioblastoma

Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive immunotherapy of B-cell malignancies

Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics

Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype

Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

Suchergebnisse filtern